Want to see CME full AI Analyst Report?
CME Stock Chart & Stats
$277.32
$0.99(0.39%)
At close: 4:00 PM EDT
$277.32
$0.99(0.39%)
Day’s Range― - ―
52-Week Range$218.31 - $329.16
Previous CloseN/A
Volume1.81M
Average Volume (3M)1.77M
Market Cap
$105.67B
Enterprise Value$81.37B
Total Cash (Recent Filing)$2.28B
Total Debt (Recent Filing)$3.42B
Price to Earnings (P/E)24.8
Beta0.15
Next Earnings
Oct 21, 2026EPS Estimate
2.98Next Dividend Ex-DateN/A
Dividend Yield3.85%
Share Statistics
EPS (TTM)11.85
Shares Outstanding359,576,100
10 Day Avg. Volume1,991,870
30 Day Avg. Volume1,767,422
Financial Highlights & Ratios
PEG Ratio1.59
Price to Book (P/B)3.42
Price to Sales (P/S)15.06
P/FCF Ratio23.42
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue12.01
Enterprise Value/Gross Profit14.67
Enterprise Value/Ebitda14.70
Forecast
1Y Price Target
$280.50Price Target Upside1.15% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)12.32
Revenue Forecast (FY)$7.05B
Bulls Say, Bears Say
Bulls Say
Market Data GrowthSustained market-data growth adds a recurring, subscription-like revenue stream that is less dependent on daily trading volumes. Thirty-three consecutive quarters of year-over-year gains indicate durable customer demand and strengthen CME’s diversified earnings base over the coming periods.
Trading Volume And Open InterestRising volume and open interest demonstrate broadening use of CME’s derivatives marketplace across products and customers. Higher activity supports transaction-fee revenue, improves liquidity, and reinforces the network benefits of CME’s established global exchange infrastructure.
Profitability And Balance SheetExceptional profitability combined with conservative leverage gives CME substantial financial flexibility. Strong earnings capacity can support technology investment, product development, dividends, and buybacks while low debt reduces balance-sheet pressure during periods of weaker market activity.
Bears Say
Regulatory Product RiskRegulatory intervention can delay or restrict CME’s planned product expansion, particularly for newer 24/7 offerings. Uncertainty around approvals and litigation timelines may raise launch costs, slow revenue contribution, and complicate the company’s ability to broaden trading access.
Perpetual Futures Demand And RiskLimited institutional demand reduces the near-term commercial potential of perpetual futures, while their structure introduces additional market and regulatory concerns. This may constrain CME’s participation in the product category and require greater caution before committing resources.
Margin CompressionLower margins indicate that some of CME’s exceptional profitability may be under pressure even as absolute earnings rise. If the compression persists, it could limit operating leverage, reduce incremental cash generation, and make future growth less efficient than historical performance.
CME Group News
CME FAQ
What was CME Group’s price range in the past 12 months?
CME Group lowest stock price was $218.31 and its highest was $329.16 in the past 12 months.
What is CME Group’s market cap?
CME Group’s market cap is $105.67B.
When is CME Group’s upcoming earnings report date?
CME Group’s upcoming earnings report date is Oct 21, 2026 which is in 2 days.
How were CME Group’s earnings last quarter?
CME Group released its earnings results on Jul 22, 2026. The company reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.905 by $0.085.
Is CME Group overvalued?
According to Wall Street analysts CME Group’s price is currently Undervalued.
Does CME Group pay dividends?
CME Group pays a Quarterly dividend of $1.3 which represents an annual dividend yield of 3.85%. See more information on CME Group dividends here
What is CME Group’s EPS estimate?
CME Group’s EPS estimate is 2.98.
How many shares outstanding does CME Group have?
CME Group has 359,576,100 shares outstanding.
What happened to CME Group’s price movement after its last earnings report?
CME Group reported an EPS of $2.99 in its last earnings report, beating expectations of $2.905. Following the earnings report the stock price went up 4.996%.
Which hedge fund is a major shareholder of CME Group?
Currently, no hedge funds are holding shares in CME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CME Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$280.50 (1.15% Upside)
$280.50 (1.15% Upside)
Blogger Sentiment
Bullish
CME Sentiment 60%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 207.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.29%
12-Months-Change
Fundamentals
Return on Equity
15.53%
Trailing 12-Months
Asset Growth
8.21%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CME Group
CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.
CME Company Deck
CME Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial performance: record Q2 revenue for the quarter, robust ADV and open interest growth, healthy margins, sizeable shareholder returns, and a clear pipeline of product innovation (24/7 trading, Single Stock futures, Compute Futures, Treasury Link). The principal negatives were regulatory uncertainty (CFTC stay and pending litigation), strategic caution and market-risk concerns around perpetual futures, and early-stage monetization for prediction markets. On balance, the positive execution, growth trends and product roadmap materially outweigh the regulatory and product-structure headwinds.View all CME earnings summariesCME Revenue Breakdown
80.99% Clearing and transaction fees
12.32% Market data and information services
6.69% Other

CME Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$280.50
▲(1.15% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cboe Global Markets
―
Intercontinental Exchange
―
S&P Global
―
Nasdaq
―
Coinbase Global
―
Ownership Overview
0.26% Insiders
23.58% Mutual Funds
2.43% Other Institutional Investors
49.36% Public Companies and Individual Investors









